COMPLEXES OF CIPROFLOXACIN WITH METAL-IONS CONTAINED IN ANTACID DRUGS

被引：20

作者：

TEIXEIRA, MHSF ^{[1
]}

VILASBOAS, LF ^{[1
]}

GIL, VMS ^{[1
]}

TEIXEIRA, F ^{[1
]}

机构：

[1] UNIV COIMBRA,FAC CIENCIAS & TECNOL,DEPT QUIM,P-3000 COIMBRA,PORTUGAL

来源：

JOURNAL OF CHEMOTHERAPY | 1995年 / 7卷 / 02期

关键词：

CIPROFLOXACIN; ANTACIDS; METAL IONS; MAGNESIUM; ALUMINUM; QUINOLONES;

D O I：

10.1179/joc.1995.7.2.126

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Simultaneous administration of antacids containing magnesium or aluminium and ciprofloxacin or other quinolones decreases the gastrointestinal absorption of those antibacterial agents. Current speculation about the mechanism of this interaction has focused on drug-cation chelation. The present study was designed to detect the protonation in solutions and the formation of the complex species at the pH levels typical of the gastrointestinal tract. It involves the study of ciprofloxacin in aqueous solutions containing Al3+ and (or) Mg2+ by combining the results of potentiometric and spectroscopic (H-1 nuclear magnetic resonance) techniques. Calculations were only performed for data in the range 4.5 < pH < 5.5 (pH levels typical of gastrointestinal tract) and the results of both methods are made self-consistent, assuming an equilibrium model including complex species MHL, MLOH (where H(2)L denotes ciprofloxacin and M is Al3+ or Mg2+); their formation constants are given.

引用

页码：126 / 132

页数：7

共 58 条

[1]

Hoffken G., Borner K., Glatzel P.D., Koeppe P., Lode H., Reduced enteral absorption of ciprofloxacin in the presence of antacids, Eur J Clin Microbiol, 4, pp. 345-348, (1985)

[2]

Preheim L.C., Cuevas T.A., Roccaforte J.S., Mellencamp M.A., Bittner M.J., Ciprofloxacin and antacids, Lancet, 2, (1986)

[3]

Fleming L.W., Morelqand T.A., Stewart W.K., Scott A.C., Ciprofloxacin and antacids, Lancet, 2, (1986)

[4]

Preheim L.C., Cuevas T.A., Roccaforte J.S., Mellencamp M.A., Bittner M.J., Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria, Am J Med, 82, 4, pp. 295-300, (1987)

[5]

Golper T.A., Hartstein A., Morthland T.H., Christensen J.M., Effects of antacids and dialysate dwell times on multiple- dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis, Antimicrob Agents Chemother, 31, 11, pp. 1787-1790, (1987)

[6]

Noyes M., Polk R., Norfloxacin and absorption of magnesium-aluminium, Ann Intern Med, 109, pp. 168-169, (1988)

[7]

Lode M., Drug interactions with quinolones, Rev Infect Dis, 10, pp. S132-SS, (1988)

[8]

Rubinstein E., Segev S., Drug interactions of ciprofloxacin with non-antibiotics agents, Am J Med, 82, pp. 119-123, (1987)

[9]

Rubinstein E., Segev S., Drug Interactions with Ciprofloxacin, pp. 44-46, (1988)

[10]

Davey P.G., Overview of drug interactions with the quinolones, J Antimicrob Chemother, 22, pp. 97-107, (1988)

← 1 2 3 4 5 6 →